trial · primary record
Saruparib
Malignant Neoplastic Disease (Disorder)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 124 |
| Primary completion | 2030-11-01 |
| Primary endpoint | Best objective response as determined by RECIST v.1.1 |
| Registry ID | NCT07832630 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:53.991Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07832630
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.